◉ HEADLINES

human trials

Promising Malaysian cancer vaccine awaits funding to begin long-delayed human trials

Seven years on, researchers say strong preclinical results persist, but lack of funding continues to hold back critical next-stage testing

Nipah virus: Oxford begins human trials for vaccine

The 51-patient trial will examine immune responses of people aged 18 to 55 to the vaccine, and more will be carried out later in a Nipah-affected country.

◉ Popular

FIFA slams FAM: Forged documents, fines and 12-month suspension rattles Malaysian football

World football’s governing body has sanctioned the Football Association of Malaysia (FAM) and seven naturalised players for using falsified documents to secure eligibility in the Asian Cup qualifier against Vietnam in June

Duck and cover? FashionValet bought Vivy’s 30 Maple for RM95 mil in 2018

Purchase of Duck's holding company which appears to be owned wholly by Datin Vivy Yusof and husband Datuk Fadzarudin Shah Anuar was made same year GLICs invested RM47 mil

Apad confirms inDrive licence revoked effective July 24, but company can appeal

Russian-based company can file appeal through the agency for the Transport Ministry's consideration